according to my searchs, could not find anything.
you can check the clinical trial website for updates
By my estimate, utrophin modulation by Summit is the most promising one.
Sanja Kogelnik said:
Utrophin ( SMT c 1100), exon skipping 51,45,53, cat 1004 I think in next 3-6 years. Maybe stem cell by dr. Riordan.
Has it the potential to treat all patients with DMD, regardless of their underlying dystrophin gene mutation ?
Michael Bazant said:
Not even in phase 1 safety trials as yet. Summit (Ezutromid) probably best near term